RxDoctor Payments DataLook up a doctor →

Matthew McDiarmid, DO

Interventional Cardiology · Thornton, CONPI 1003234162

Payments from drug & device makers

$52,137in general payments, 2019–2025

Across 650 payments — averaging $80.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Philips North America LLC$16K
  • Penumbra, Inc.$8K
  • Medtronic$3K
  • Boston Scientific$3K
  • Angiodynamics, Inc.$3K
  • Inari Medical, Inc.$2K
  • plus $18K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Philips North America LLC39$15,534
Penumbra, Inc.25$8,014
Medtronic(2 entities)48$2,939
Boston Scientific21$2,904
Angiodynamics, Inc.5$2,875
Inari Medical, Inc.27$2,195
Abbott31$2,129
Abiomed22$1,646
Bard Peripheral Vascular, Inc.16$1,383
Actelion Pharmaceuticals US, Inc.57$913
E.r. Squibb & Sons, L.L.C.35$758
Terumo Medical Corporation2$700
Edwards Lifesciences10$680
Heartflow, Inc.26$660
Shockwave Medical, Inc6$646
Impulse Dynamics (USA) Inc.9$595
Kestra Medical Technology Services, Inc.17$517
Cagent Vascular Inc4$509
Amgen22$477
Pfizer23$451
Bayer19$419
Cardiovascular Systems Inc.3$393
Novartis18$392
Johnson & Johnson21$369
Endologix LLC5$348
Novo Nordisk15$348
BD2$330
Astellas Pharma US Inc3$270
Esperion Therapeutics, Inc.13$224
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)14$219
Boehringer Ingelheim10$212
Merck9$170
Cvrx, Inc.8$165
W. L. Gore & Associates, Inc.2$147
Alnylam Pharmaceuticals Inc.5$131
AstraZeneca7$127
Biotronik Inc.1$108
Mozarc Medical US LLC1$96
Scpharmaceuticals Inc.5$93
Bridgebio Pharma, Inc.3$83
Kiniksa Pharmaceuticals International, PLC4$83
United Therapeutics Corporation3$69
Regeneron Healthcare Solutions, Inc.2$65
Tempus AI, Inc1$62
Cleerly, Inc.3$60
Akcea Therapeutics, Inc.1$59
Veryan Medical Incorporated1$54
Cardiva Medical, Inc.2$47
Irhythm Technologies, Inc.1$46
Baxter Healthcare2$45
Lexicon Pharmaceuticals, Inc.3$43
Lilly USA, LLC2$43
Kiniksa Pharmaceuticals, Ltd.2$40
Sanofi-aventis U.S. LLC2$29
Smith+Nephew1$26
Ossur Americas, Inc.1$26
Recor Medical Inc1$22
Biowound Solutions, Inc.1$20
CSL Behring1$19
Atricure, Inc.1$19

How this compares

$52,137 in reported general payments places this provider in the 65th percentile of 111 interventional cardiology providers in Colorado.

See all interventional cardiology providers in Colorado

Medicare billing

Part B allowed, 2024
$356,798
Medicare patients
408
Services billed
3,643

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Thornton

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →